Other

USO 11180 A Randomized, Double-Blinded, Placebo-Controlled Phase III Trial To Evaluate The Effectiveness of a Phosphodiesterase 5 Inhibitor, Tadalafil, in Prevention of Erectile Dysfunction in Patients Treated with Radiotherapy for Prostate Cancer (RTOG 0831)

USO 11107-SGN00-001: Screening protocol to detect tumor antigen expression required for enrollment on clinical research protocols of antibody-directed therapy

Please contact the NYOH Research Department for more information on clinical trials at (518) 489-0044 ext. 1239